HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America
Authors:
- Carolina Bernabe-RamirezCBCarolina Bernabe-Ramirez
- Ana I. VelazquezAVAna I. Velazquez
- Coral OlazagastiCOCoral Olazagasti
- Cristiane Decat BergerotCBCristiane Decat Bergerot
- Paulo Gustavo BergerotPBPaulo Gustavo Bergerot
- Jose Corona CruzJCJose Corona Cruz
- Ivy RianoIRIvy Riano
- Christina AdanielCAChristina Adaniel
- Jesus AnampaJAJesus Anampa
Open Access
- 4 March 2022
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 8 (8) , e2100251
Abstract
PURPOSE: The HOLA COVID-19 study sought to evaluate the impact of COVID-19 on oncology practices across Latin America (LATAM), challenges faced by physicians, and how practices and physicians adapted while delivering care to patients with cancer.METHODS: This international cross-sectional study of oncology physicians in LATAM included a 43-item anonymous online survey to evaluate changes and adaptations to clinical practice. Multivariable logistic regression analyses were used to evaluate the association of caring for patients with COVID-19 and changes to clinical practice.RESULTS: A total of 704 oncology physicians from 19 countries completed the survey. Among respondents, the most common specialty was general oncology (34%) and 56% of physicians had cared for patients with COVID-19. The majority of physicians (70%) noted a decrease in the number of new patients evaluated during the COVID-19 pandemic when compared with prepandemic, and 73% reported adopting the use of telemedicine in their practice. More than half (58%) of physicians reported making changes to the treatments that they offered to patients with cancer. In adjusted models, physicians who had cared for patients with COVID-19 had higher odds of changing the type of chemotherapy or treatments that they offered (adjusted odds ratio 1.81; 95% CI, 1.30 to 2.53) and of delaying chemotherapy start (adjusted odds ratio 2.05; 95% CI, 1.49 to 2.81). Physicians identified significant delays in access to radiation and surgical services, diagnostic tests, and supportive care.CONCLUSION: The COVID-19 pandemic has significantly disrupted global cancer care. Although changes to health care delivery are a necessary response to this global crisis, our study highlights the significant disruption and changes to the treatment plans of patients with cancer in LATAM resulting from the COVID-19 health care crisis.Keywords
This publication has 24 references indexed in Scilit:
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling studyThe Lancet Oncology, 2020
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyThe Lancet, 2020
- Early impact of the COVID-19 pandemic on paediatric cancer care in Latin AmericaThe Lancet Oncology, 2020
- Oncology Practice During the COVID-19 PandemicJAMA, 2020
- How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?Annals of Internal Medicine, 2020
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakCancer Discovery, 2020
- Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemicNature Reviews Clinical Oncology, 2020
- Cancer patterns and trends in Central and South AmericaCancer Epidemiology, 2016
- Understanding and interpreting generalized ordered logit modelsThe Journal of Mathematical Sociology, 2016
- Generalized Ordered Logit/Partial Proportional Odds Models for Ordinal Dependent VariablesThe Stata Journal: Promoting communications on statistics and Stata, 2006